CUSIP 297584104COMESLAQ4 2025
1 filings · latest Oct 30, 2023
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Oct 30, 2023 | Eureka Therapeutics, Inc. | 13D | 71.8% | 25.28M | SEC |
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vanguard Group Inc | 448.8K | $700.1K |
| 2 | Renaissance Technologies LLC | 122.5K | $191.1K |
| 3 | Geode Capital Management, LLC | 109.8K | $171.3K |
| 4 | Citadel Advisors LLC | 64.4K | $100.5K |
| 5 | Marshall Wace, LLP | 56.2K | $87.7K |
| 6 | Xtx Topco Ltd | 49.5K | $77.2K |
| 7 | State Street Corp | 43.3K | $67.5K |
| 8 | Quadrature Capital Ltd | 27.8K | $43.3K |
| 9 |
| 26.5K |
| $41.3K |
| 10 | Northern Trust Corp | 19.6K | $30.6K |